Compass Pathways PLC - American Depository Shares (CMPS) closed at $8.65 on November 19, 2026, up 6.5% from the previous close, on volume of 2,815,194 shares (30-day average 3,252,288).
Data as of November 19, 2026.
19-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Call Spread | 21-May-2712 : 20 C | 6,960 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 18, 2026. See the largest for 5, 30, 60 and 90 days
Compass Pathways to Participate in 9th Annual Evercore Healthcare Conference on December 1
Business Wire (Thu, 19-Nov 6:30 AM ET)
Analysts Offer Insights on Healthcare Companies: TRex Bio, Inc. (TRXB) and COMPASS Pathways (CMPS)
TipRanks (Tue, 17-Nov 2:00 AM ET)
Compass Pathways Earnings Call Signals 2027 Launch Momentum
TipRanks (Sun, 15-Nov 7:09 PM ET)
Compass Pathways to Participate in Jefferies Global Healthcare Conference on November 18th and 19th
Business Wire (Wed, 11-Nov 6:30 AM ET)
Business Wire (Mon, 9-Nov 6:30 AM ET)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Thu, 5-Nov 4:30 PM ET)
Compass Pathways to Participate in Stifel 2026 Healthcare Conference on November 11th
Business Wire (Wed, 4-Nov 6:30 AM ET)
Compass Pathways Spotlights the Human Cost of Treatment-Resistant Depression in New National Survey
Market Chameleon (Tue, 3-Nov 6:38 AM ET)
Market Chameleon (Tue, 3-Nov 2:07 AM ET)
Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights
Business Wire (Tue, 3-Nov 6:30 AM ET)
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.
As of November 19, 2026, CMPS stock price climbed to $8.65 with 2,815,194 million shares trading.
CMPS has a beta of 2.77, meaning it tends to be more sensitive to market movements. CMPS has a correlation of 0.17 to the broad based SPY ETF.
CMPS has a market cap of $1.17 billion. This is considered a Small Cap stock.
In the last 3 years, CMPS traded as high as $15.87 and as low as $2.25.
The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, SBIO, TMSL.
CMPS has outperformed the market in the last year with a price return of +60.5% while the SPY ETF gained +9.6%. However, in the short term, CMPS had mixed performance relative to the market. It has underperformed in the last 3 months, returning -37.8% vs -6.5% return in SPY. But in the last 2 weeks, CMPS shares have fared better than the market returning +0.6% compared to SPY -6.6%.
CMPS support price is $7.74 and resistance is $8.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.